Information on the target
Crescentia Capital is pleased to announce that its portfolio company, Synsus, has successfully acquired Emerald Bioagriculture, a respected innovator in biostimulant technologies. Synsus is recognized as an industry leader, providing end-to-end, custom-formulated solutions to agricultural, turf, and consumer lawn and garden brands and retailers on a global scale. This acquisition is poised to enhance Synsus' diverse portfolio of eco-friendly solutions aimed at growers, turf managers, and homeowners worldwide.
The integration of Emerald's innovative technologies and product lines into Synsus' existing offerings is expected to drive significant advancements in sustainable agricultural practices. With a strong commitment to research and development, Synsus aims to leverage its state-of-the-art R&D platform and extensive formulation expertise to create new products that meet the evolving needs of its customers.
Industry overview in the target’s specific country
The biostimulant industry has been experiencing robust growth, driven by increasing demand for sustainable agricultural practices and the need for eco-friendly solutions. In the United States, the market for biostimulants is projected to expand significantly as farmers and growers seek alternatives to traditional chemical fertilizers and pesticides. This shift is largely influenced by consumer preferences for organic and sustainably produced food, as well as regulatory pressures to reduce chemical usage in agriculture.
Emerald Bioagriculture has positioned itself as a key player in this evolving landscape, developing specially formulated bio nutrient products that enhance plant growth while minimizing environmental impact. Their innovative solutions enable plants to better absorb and utilize nutrients, thereby improving overall productivity and sustainability in agricultural practices.
As the industry continues to evolve, the integration of biostimulant technologies into conventional farming practices is expected to accelerate. This trend is supported by ongoing research and development efforts aimed at improving product efficacy and expanding the range of applications for biostimulants across various crops and growing conditions. The collaboration between Synsus and Emerald is well-timed to capitalize on these market dynamics, offering a broader range of solutions to meet the needs of modern agriculture.
The rationale behind the deal The acquisition of Emerald Bioagriculture by Synsus represents a strategic move to enhance Synsus' capabilities in delivering innovative biostimulant solutions. By combining resources and expertise, the two compani…